Land: Australien
Sprache: Englisch
Quelle: Department of Health (Therapeutic Goods Administration)
morphine sulfate pentahydrate, Quantity: 30 mg
Arrotex Pharmaceuticals Pty Ltd
Tablet, uncoated
Excipient Ingredients: magnesium stearate; lactose; croscarmellose sodium
Oral
20 tablets, 10 tablets, 6 tablets, 8 tablets
(S8) Controlled Drug
Anamorph is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.
Visual Identification: Round white flat bevelled edge tablet 5/16" diameter, scored on one side and marked with letter M above breakline and the numeral 30 below; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1991-12-11
ANAMORPH- Consumer Medicine Information Page 1 of 5 ANAMORPH TABLETS morphine sulfate pentahydrate CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ANAMORPH tablets. It does not contain all the available information about this medicine. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking ANAMORPH against the benefits they expect it will have for you. ASK YOUR DOCTOR OR PHARMACIST IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT IS ANAMORPH USED FOR The name of your medicine is ANAMORPH. It is available as a 30 mg tablet. The active ingredient is called morphine sulfate . Morphine sulfate belongs to a group of medicines called analgesics. It is an opioid analgesic, and it acts in the central nervous system by blocking pain and your emotional response to pain. ANAMORPH is used to treat moderate to severe pain. Your doctor however may have prescribed ANAMORPH for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY ANAMORPH HAS BEEN PRESCRIBED FOR YOU. This medicine only available with a doctor’s prescription. ANAMORPH may be habit-forming, so it is important to take it exactly as directed by your doctor. AS WITH ALL OTHER OPIOID CONTAINING PRODUCTS, YOUR BODY MAY BECOME USED TO YOU TAKING ANAMORPH. TAKING IT MAY RESULT IN PHYSICAL DEPENDENCE. PHYSICAL DEPENDENCE MEANS THAT YOU MAY EXPERIENCE WITHDRAWAL SYMPTOMS IF YOU STOP TAKING ANAMORPH SUDDENLY, SO IT IS IMPORTANT TO TAKE IT EXACTLY AS DIRECTED BY YOUR DOCTOR. WARNING LIMITATIONS OF USE should only be used when your doctor decides that other treatment options are not able to effectively manage your pain or you cannot tolerate them. HAZARDOUS AND HARMFUL USE ANAMORPH poses risks of abuse, misuse and addiction which can lead to overdose and death. Your doctor will monitor you regularly during treatment. LIFE TH Lesen Sie das vollständige Dokument
1 AUSTRALIAN PRODUCT INFORMATION ANAMORPH (MORPHINE SULFATE PENTAHYDRATE) TABLET WARNINGS _LIMITATIONS OF USE _ Because of the risks associated with the use of opioids, Anamorph should only be used in patients for whom other treatment options, including non-opioid analgesics, are ineffective, not tolerated or otherwise inadequate to provide appropriate management of pain (see _section 4.4 Special Warnings and Precautions for Use_). _HAZARDOUS AND HARMFUL USE _ Anamorph poses risks of hazardous and harmful use which can lead to overdose and death. Assess the patient’s risk of hazardous and harmful use before prescribing and monitor the patient regularly during treatment (see _section 4.4. Special Warnings and Precautions for _ _Use_). _LIFE THREATENING RESPIRATORY DEPRESSION _ Serious, life-threatening or fatal respiratory depression may occur with the use of Anamorph. Be aware of situations which increase the risk of respiratory depression, modify dosing in patients at risk and monitor patients closely, especially on initiation or following a dose increase (see _section 4.4 Special Warnings and Precautions for Use_). _CONCOMITANT USE OF BENZODIAZEPINES AND OTHER CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANTS, _ _INCLUDING ALCOHOL _ Concomitant use of opioids with benzodiazepines, gabapentinoids, antihistamines, tricyclic, antidepressants, antipsychotics, cannabis or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Limit dosages and durations to the minimum required; and monitor patients for signs and symptoms of respiratory depression and sedation. Caution patients not to drink alcohol while taking Anamorph. 1 NAME OF THE MEDICINE Morphine sulfate pentahydrate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Morphine is a phenanthrene-derivative opiate agonist. Morphine is the chief opium alkaloid which is dried or partially dried latex from the capsules of _Papaver sonniferum_. Anamorph tablets: Each tablet contains 30 mg morphine Lesen Sie das vollständige Dokument